Gambaran Faktor Risiko Penyakit Tidak Menular Berdasarkan Hasil Skrining Peserta Posbindu Rosella Kembangan Selatan

Susy Olivia Lontoh; Chrismerry Song; Ernawati Ernawati

doi:10.61132/mengabdi.v3i6.2076

Authors

Susy Olivia Lontoh Universitas Tarumanagara
Chrismerry Song Universitas Tarumanagara
Ernawati Ernawati Universitas Tarumanagara

DOI:

https://doi.org/10.61132/mengabdi.v3i6.2076

Keywords:

Clinical Guidelines, Community-Based Health, Health Screening, Non-Communicable Diseases, Posbindu PTM

Abstract

Non-communicable diseases (NCDs) are the leading causes of morbidity and mortality, particularly among older adults. Integrated Development Posts for Non-Communicable Diseases (Pos Pembinaan Terpadu Penyakit Tidak Menular / Posbindu PTM) play a crucial role in the early detection of NCD risk factors at the community level. This activity aimed to conduct NCD risk factor screening through the measurement of blood pressure, random blood glucose, total cholesterol, and uric acid levels, as well as to provide health consultations for participants of Posbindu Rosella, South Kembangan. The activity was conducted in November 2025 using a descriptive design. A total of 30 Posbindu participants were involved. Health examinations included blood pressure, random blood glucose, total cholesterol, and uric acid measurements. Data were analyzed descriptively and classified into normal and abnormal categories based on clinical guidelines. The majority of participants were female (80%), with a mean age of 60.5 ± 9.7 years. The mean systolic blood pressure was within the hypertensive range. Approximately 50% of participants had impaired glucose regulation, 60% experienced hyperuricemia, and 40% had total cholesterol levels classified as borderline or higher. Health screening activities at Posbindu revealed a high prevalence of NCD risk factors among participants. Posbindu plays an essential role in early detection and community-based prevention of non-communicable diseases.

Downloads

Download data is not yet available.

References

Ahmed, S. K., & Mohammed, R. A. (2025). Obesity: Prevalence, causes, consequences, management, preventive strategies, and future research directions. Metabolism Open, 27, 100375. https://doi.org/10.1016/j.metop.2025.100375

Arini, M., & Primastuti, H. I. (2023). Inisiasi pendirian Posyandu Lansia Jomboran, Sleman melalui pelatihan dan pendampingan kader kesehatan. Poltekita: Jurnal Pengabdian Masyarakat, 4(1), 140–151. https://doi.org/10.33860/pjpm.v4i1.1461

Azam, M., Sakinah, L. F., Kartasurya, M. I., Fibriana, A. I., Minuljo, T. T., & Aljunid, S. M. (2023). Prevalence and determinants of obesity among individuals with diabetes in Indonesia. F1000Research, 11, 1063. https://doi.org/10.12688/f1000research.125549.4

Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016). Gout. The Lancet, 388(10055), 2039–2052. https://doi.org/10.1016/S0140-6736(16)00346-9

GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9

Global Burden of Disease Collaborative Network. (2024). Global Burden of Disease Study 2021 (GBD 2021) results. Institute for Health Metrics and Evaluation. https://vizhub.healthdata.org/gbd-results/

Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., & Yeboah, J. (2019). 2018 AHA/ACC guideline on the management of blood cholesterol. Circulation, 139(25), e1082–e1143. https://doi.org/10.1161/CIR.0000000000000625

International Diabetes Federation. (2021). IDF diabetes atlas (10th ed.). International Diabetes Federation.

Kementerian Kesehatan Republik Indonesia. (2019). Petunjuk teknis pos pembinaan terpadu penyakit tidak menular (Posbindu PTM). Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2022). Profil kesehatan Indonesia 2021. Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2025, February 19). Government strengthens GGL policy to control non-communicable diseases. Badan Kebijakan Pembangunan Kesehatan. https://www.badankebijakan.kemkes.go.id/en/pemerintah-perkuat-kebijakan-ggl-untuk-kendalikan-penyakit-tidak-menular/

Kuwabara, M., Niwa, K., Hisatome, I., Hamada, T., Ninomiya, T., Hara, S., Nakagawa, T., & Yamamoto, T. (2017). Asymptomatic hyperuricemia and cardiovascular disease. Hypertension Research, 40(6), 603–608. https://doi.org/10.1038/hr.2017.13

Murray, C. J. L. (2024). Findings from the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2259–2262. https://doi.org/10.1016/S0140-6736(24)00661-4

NCD Risk Factor Collaboration (NCD-RisC). (2017). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19.1 million participants. The Lancet, 389(10064), 37–55. https://doi.org/10.1016/S0140-6736(16)31919-5

Nugrahaeni, D. K., Mauliku, N. E., & Budiana, T. A. (2023). Early detection of risk factors for non-communicable diseases. Faletehan Health Journal, 10(1), 9–17. https://doi.org/10.33746/fhj.v10i01.483

Prameswari, R. D., Revita, N. C. T., Angraini, D. A., & Asfarina, I. (2024). Epidemiological analysis of non-communicable diseases in Indonesia in the post-COVID-19 era. Indonesian Journal of Global Health Research, 7(1), 617–626. https://doi.org/10.37287/ijghr.v7i1.4665

Rahajeng, E. (2020). Penguatan Posbindu PTM dalam menurunkan prevalensi faktor risiko penyakit tidak menular utama. Lembaga Penerbit Badan Litbangkes. https://repository.badankebijakan.kemkes.go.id/id/eprint/3928/

Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., Williams, R., & IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843

World Health Organization. (2023). Noncommunicable diseases. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

World Health Organization. (2025). Strengthening collaborative efforts for improved noncommunicable disease interventions in Indonesia. Knowledge Action Portal on NCDs. https://knowledge-action-portal.com/en/content/strengthening-collaborative-efforts-improved-ncd-interventions-indonesia